| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Gillian K Reeves | Q73562500 |
| Paul N. Appleby | Q105082783 | ||
| P2093 | author name string | Timothy J Key | |
| Andrew W Roddam | |||
| Endogenous Hormones and Breast Cancer Collaborative Group | |||
| P2860 | cites work | The effect of cigarette smoking use and cessation on serum insulin-like growth factors | Q28212548 |
| Cellular actions of the insulin-like growth factor binding proteins | Q28216659 | ||
| Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer | Q28298007 | ||
| Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects | Q28365959 | ||
| Insulin and insulin-like growth factor signalling in neoplasia | Q29619495 | ||
| Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group | Q33539260 | ||
| Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones | Q33541391 | ||
| Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. | Q34530900 | ||
| The role of the IGF system in cancer growth and metastasis: overview and recent insights | Q36576678 | ||
| A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk | Q36616549 | ||
| Normal levels of serum IGF-I: determinants and validity of current reference ranges | Q36814888 | ||
| Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women | Q37090766 | ||
| IGF binding proteins (IGFBPs) and regulation of breast cancer biology. | Q37334106 | ||
| 6 Factors controlling blood concentration of somatomedin C | Q40109950 | ||
| Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. | Q40196099 | ||
| Presence of somatomedin receptors on primary human breast and colon carcinomas | Q41356905 | ||
| Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture | Q41560045 | ||
| Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort | Q42730604 | ||
| Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. | Q43290059 | ||
| A cross-sectional study of IGF-I determinants in women | Q43801437 | ||
| Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies | Q43963634 | ||
| Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. | Q44132475 | ||
| Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer | Q44159735 | ||
| Fasting glucose is a risk factor for breast cancer: a prospective study. | Q44217805 | ||
| Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. | Q44258859 | ||
| Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. | Q45040888 | ||
| Effects of alcohol and menstrual cycle on insulin-like growth factor-I and insulin-like growth factor binding protein-3. | Q45187125 | ||
| Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women | Q45188730 | ||
| The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. | Q46021252 | ||
| Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study | Q46118799 | ||
| Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition | Q46831183 | ||
| Are mammotropic hormones mainly permissive for the development of breast cancer? | Q46870613 | ||
| Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study | Q47742170 | ||
| Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer | Q47850375 | ||
| Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. | Q51542373 | ||
| Serum insulin-like growth factor-I and breast cancer. | Q51552786 | ||
| Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). | Q52033912 | ||
| Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. | Q55034277 | ||
| IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC) | Q56336664 | ||
| IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies | Q57037834 | ||
| Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer | Q57265750 | ||
| Variation in Plasma Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3: Personal and Lifestyle Factors (United States) | Q57268404 | ||
| Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays | Q57420872 | ||
| Circulating concentrations of insulin-like growth factor I and risk of breast cancer | Q57751183 | ||
| Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer | Q70565385 | ||
| Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women | Q73798681 | ||
| Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women | Q73806189 | ||
| Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 | Q74593409 | ||
| Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies | Q78556985 | ||
| Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women | Q79182457 | ||
| Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women | Q80980174 | ||
| Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer | Q80988824 | ||
| Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays | Q81043109 | ||
| Effects of alcohol on insulin-like growth factor I and insulin-like growth factor binding protein 3 in postmenopausal women | Q81378084 | ||
| Body shape throughout life and correlations with IGFs and GH | Q81392065 | ||
| Insulin-like growth factor I levels in healthy adults | Q81509248 | ||
| Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk | Q81521821 | ||
| Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway | Q81793347 | ||
| Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period | Q83348610 | ||
| Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II | Q83854288 | ||
| P433 | issue | 6 | |
| P921 | main subject | breast cancer | Q128581 |
| preproinsulin | Q7240673 | ||
| data analysis | Q1988917 | ||
| P304 | page(s) | 530-542 | |
| P577 | publication date | 2010-05-14 | |
| P1433 | published in | Lancet Oncology Commission | Q13747613 |
| P1476 | title | Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies | |
| P478 | volume | 11 |
| Q58764289 | A Dietary Intervention to Lower Serum Levels of IGF-I in Mutation Carriers |
| Q36253842 | A Liver-Bone Endocrine Relay by IGFBP1 Promotes Osteoclastogenesis and Mediates FGF21-Induced Bone Resorption |
| Q33901385 | A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk |
| Q37200490 | A comparison of hormonal profiles between breast cancer and benign breast disease: a case-control study |
| Q45305326 | A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. |
| Q47418110 | A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC). |
| Q61771629 | A randomized controlled trial of diet and physical activity in BRCA mutation carriers |
| Q41201476 | A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers. |
| Q36100606 | A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor |
| Q57177354 | Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions |
| Q35815820 | Adolescent and Early Adulthood Dietary Carbohydrate Quantity and Quality in Relation to Breast Cancer Risk |
| Q37171420 | Adolescent fiber intake and mammographic breast density in premenopausal women |
| Q55004788 | Adult height and all-cause and cause-specific mortality in the Japan Public Health Center-based Prospective Study (JPHC). |
| Q38821481 | Alcohol Use and Breast Cancer: A Critical Review |
| Q36338202 | An integrated method for the identification of novel genes related to oral cancer |
| Q92122604 | Animal foods and postmenopausal breast cancer risk: a prospective cohort study |
| Q44669149 | Animal protein intakes during early life and adolescence differ in their relation to the growth hormone-insulin-like-growth-factor axis in young adulthood |
| Q42457782 | Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women |
| Q34431333 | Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma |
| Q92355610 | Apoptosis and metastasis inhibitory potential of pineapple vinegar against mouse mammary gland cells in vitro and in vivo |
| Q33848720 | Assessment of age-related changes in heritability and IGF-1 gene effect on circulating IGF-1 levels |
| Q24595013 | Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study |
| Q34490646 | Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis |
| Q34240707 | Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival |
| Q35763352 | Association between height and malignancy among children in the north of Iran. |
| Q56089359 | Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women |
| Q38399478 | Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q36121423 | Association of insulin-like growth factor-1 with thyroid nodules |
| Q99711981 | Associations Between Circulating Insulin-Like Growth Factor 1 and Mortality in Women With Invasive Breast Cancer |
| Q37151431 | Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer |
| Q37587325 | Associations of ionizing radiation and breast cancer-related serum hormone and growth factor levels in cancer-free female A-bomb survivors |
| Q38232943 | Birthweight, early life body size and adult mammographic density: a review of epidemiologic studies |
| Q100467277 | Body fatness and mTOR pathway activation of breast cancer in the Women's Circle of Health Study |
| Q50052082 | Body fatness at a young age, body fatness gain and risk of breast cancer: systematic review and meta-analysis of cohort studies. |
| Q36674759 | Body mass index and breast cancer: analysis of a nation-wide population-based prospective cohort study on 1 393 985 Taiwanese women. |
| Q30458239 | Body mass index, diabetes, and triple-negative breast cancer prognosis |
| Q35195567 | Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 |
| Q43954762 | Bone mineral density and risk of breast cancer in postmenopausal women |
| Q49262734 | Breast cancer risk factors and mammographic density among high-risk women in urban China. |
| Q42286112 | Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue |
| Q36903909 | CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy |
| Q35833801 | Cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai |
| Q47254581 | Carbohydrates, glycemic index, glycemic load, and breast cancer risk: a systematic review and dose-response meta-analysis of prospective studies |
| Q38901717 | Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies |
| Q35034838 | Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. |
| Q45667285 | Childhood factors associated with mammographic density in adult women. |
| Q37479093 | Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study |
| Q34310978 | Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in women |
| Q35805508 | Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort |
| Q35156893 | Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer |
| Q36592089 | Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease |
| Q62592970 | Circulating insulin‐like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition |
| Q36357195 | Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad? |
| Q88108152 | Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer |
| Q39260731 | Cloning and expression of full-length human insulin-like growth factor binding protein 3 (IGFBP3) in the Escherichia coli |
| Q44748014 | Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy |
| Q36971053 | Community-based participatory research to improve life quality and clinical outcomes of patients with breast cancer (DianaWeb in Umbria pilot study) |
| Q35241200 | Comparison of radioimmuno and carbon nanotube field-effect transistor assays for measuring insulin-like growth factor-1 in a preclinical model of human breast cancer |
| Q24614574 | Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium |
| Q35835118 | Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition |
| Q37984124 | Curcumin molecular targets in obesity and obesity-related cancers |
| Q88537052 | Dairy Consumption in Adolescence and Early Adulthood and Risk of Breast Cancer |
| Q34443695 | Defining the genomic signature of the parous breast |
| Q92282083 | Determinants of Mammographic Density Change |
| Q37832965 | Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies |
| Q86316589 | Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies |
| Q38232006 | Diabetes mellitus: influences on cancer risk |
| Q84072202 | Diet, insulin-like growth factor-1 and cancer risk |
| Q37318388 | Dietary patterns and breast cancer risk in the California Teachers Study cohort |
| Q37589151 | Dietary protein restriction inhibits tumor growth in human xenograft models |
| Q36998212 | Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors |
| Q50083416 | Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention. |
| Q51531354 | Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma. |
| Q99402863 | Does insulin-like growth factor moderate the association between height and risk of cancer at 24 sites? |
| Q38854760 | Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1). |
| Q89429102 | Effect of exercise on metabolic syndrome in black women by family history and predicted risk of breast cancer: The FIERCE Study |
| Q34159376 | Effect of low-intensity aerobic exercise on insulin-like growth factor-I and insulin-like growth factor-binding proteins in healthy men |
| Q26773326 | Effects of obesity on hormonally driven cancer in women |
| Q64275727 | Effects of short-term fasting on cancer treatment |
| Q96132782 | Elevated Levels of circRUNX1 in Colorectal Cancer Promote Cell Growth and Metastasis via miR-145-5p/IGF1 Signalling |
| Q42365262 | Endoplasmic reticulum stress induces autophagy and apoptosis while inhibiting proliferation and drug resistance in multiple myeloma through the PI3K/Akt/mTOR signaling pathway |
| Q47805414 | Energy Balance Modulation Impacts Epigenetic Reprogramming, ERα and ERβ Expression, and Mammary Tumor Development in MMTV-neu Transgenic Mice |
| Q92446005 | Energy Restriction and Colorectal Cancer: A Call for Additional Research |
| Q92916929 | Epidemiology of Breast Cancer in Women |
| Q28391921 | Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? |
| Q28087055 | Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3? |
| Q53215513 | Estrogen and insulin replacement therapy modulates the expression of insulin-like growth factor-I receptors in the salivary glands of diabetic mice. |
| Q39110788 | Every exercise bout matters: linking systemic exercise responses to breast cancer control. |
| Q36380474 | Exercise-induced lung cancer regression: mechanistic findings from a mouse model |
| Q36511817 | Expression of PI3Kp110α and PI3Kp110β in the colorectal conventional adenoma, serrated lesions and adenoma with canceration and their significance |
| Q35218640 | Expression of estrogen receptors in non-malignant mammary tissue modifies the association between insulin-like growth factor 1 and breast cancer risk |
| Q47834896 | Expression of kit ligand and insulin-like growth factor binding protein 3 during in vivo or in vitro development of ovarian follicles in sheep. |
| Q36785358 | Fast Principal-Component Analysis Reveals Convergent Evolution of ADH1B in Europe and East Asia |
| Q92881108 | Female Specific Association of Low Insulin-Like Growth Factor 1 (IGF1) Levels with Increased Risk of Premature Mortality in Renal Transplant Recipients |
| Q35920972 | Fetal growth and subsequent maternal risk of colorectal cancer |
| Q36852834 | Fetal growth and subsequent maternal risk of thyroid cancer |
| Q91580514 | Fiber consumption and breast cancer incidence: A systematic review and meta-analysis of prospective studies |
| Q35073592 | Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway |
| Q34999480 | Fracture in asian women with breast cancer occurs at younger age |
| Q38640174 | Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study |
| Q36089874 | GSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo |
| Q34294117 | Genetic and dietary determinants of insulin-like growth factor (IGF)-1 and IGF binding protein (BP)-3 levels among Chinese women |
| Q34380477 | Genetic variability in IGF-1 and IGFBP-3 and body size in early life |
| Q37482022 | Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium |
| Q64896350 | Genetically determined height was associated with lung cancer risk in East Asian population. |
| Q35061252 | Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q31137734 | Genomic interaction profiles in breast cancer reveal altered chromatin architecture |
| Q34303594 | Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort |
| Q38061213 | Glycaemic index and glycaemic load in relation to risk of diabetes-related cancers: a meta-analysis |
| Q43657929 | Glycemic index, glycemic load and cancer risk |
| Q92709430 | Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer |
| Q34337938 | Green tea and breast cancer |
| Q47176435 | Growth Trajectories, Breast Size, and Breast-Tissue Composition in a British Pre-Birth Cohort of Young Women |
| Q37801276 | Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. |
| Q40596331 | Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q42364344 | Height and lung cancer risk: A meta-analysis of observational studies |
| Q43518068 | Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study |
| Q47324089 | Height: a universal cancer risk factor? |
| Q64994804 | High Bone Mineral Density of the Lumbar Spine Is Positively Associated with Breast Cancer. |
| Q34774874 | High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy |
| Q52662346 | Hormone Use in Food Animal Production: Assessing Potential Dietary Exposures and Breast Cancer Risk. |
| Q53232395 | Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor. |
| Q27334603 | Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts |
| Q94546957 | IGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive Breast Cancer Patients |
| Q38062611 | IGF-1 and BRCA1 signalling pathways in familial cancer |
| Q54545081 | IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. |
| Q54398392 | IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families. |
| Q37439397 | IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation |
| Q47612265 | Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis |
| Q46984158 | Increased Igf-I/Igfbp-3 Ratios in Postmenopausal Taiwanese with Breast Cancer, Irrespective of Er and Pr Statuses and Her2 Expression in a Case-Control Study. |
| Q55369032 | Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis. |
| Q37087351 | Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling |
| Q37997180 | Insulin resistance: a significant risk factor of endometrial cancer |
| Q36111455 | Insulin-like growth factor 1 gene polymorphism and breast cancer risk among arab omani women: a case-control study |
| Q33164143 | Insulin-like growth factor 1 predicts post-load hypoglycemia following bariatric surgery: a prospective cohort study |
| Q36433403 | Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01) |
| Q53082610 | Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort. |
| Q54388154 | Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma. |
| Q46098680 | Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen. |
| Q34636364 | Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis |
| Q36074111 | Insulin-like growth factor-1 signaling in renal cell carcinoma |
| Q48571568 | Insulin-like growth factor-1, growth hormone, and daily cycling estrogen are associated with mammographic density in premenopausal women. |
| Q36245524 | Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II |
| Q90311446 | Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women |
| Q36968614 | Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies |
| Q64904960 | Insulin-like growth factor-1, metabolic abnormalities, and pathological complete remission rate in HER2-positive breast cancer patients receiving neoadjuvant therapy. |
| Q38128225 | Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection. |
| Q33716534 | Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition |
| Q37047067 | Insulin-like growth factor: current concepts and new developments in cancer therapy |
| Q34066320 | Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer |
| Q47279238 | Is body size associated with ovarian cancer in southern Chinese women? |
| Q28069262 | Is there a role for IGF-1 in the development of second primary cancers? |
| Q57180538 | Leptin stimulates IGF-1 transcription by activating AP-1 in human breast cancer cells |
| Q92897339 | Linkage Between Obesity Leptin and Breast Cancer |
| Q36694319 | Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism |
| Q45399201 | Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition |
| Q28074177 | Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies |
| Q53713060 | Maternal and cord blood hormone levels in the United States and China and the intrauterine origin of breast cancer. |
| Q50132021 | Melatonin: A Molecule for Reducing Breast Cancer Risk. |
| Q47685031 | Menstrual cycle characteristics and steroid hormone, prolactin, and growth factor levels in premenopausal women |
| Q51273081 | Metabolic syndrome and incidence of breast cancer in middle-aged Korean women: a nationwide cohort study. |
| Q92026591 | Milk and Dairy Product Consumption and Prostate Cancer Risk and Mortality: An Overview of Systematic Reviews and Meta-analyses |
| Q35984100 | Milk, dairy intake and risk of endometrial cancer: a 26-year follow-up |
| Q97521007 | Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K/Akt Pathway Provide Clues? |
| Q58776408 | Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers |
| Q36988816 | Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. |
| Q34359901 | No association of risk variants for diabetes and obesity with breast cancer: the Multiethnic Cohort and PAGE studies |
| Q30539342 | Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression |
| Q35999273 | Novel epigenetic determinants of type 2 diabetes in Mexican-American families |
| Q91656664 | Nutrition and Breast Cancer: A Literature Review on Prevention, Treatment and Recurrence |
| Q39026672 | Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective. |
| Q39026644 | Obesity and Breast Cancer |
| Q92408676 | Obesity and Breast Cancer: Role of Leptin |
| Q41673272 | Obesity and Cancer Metabolism: A Perspective on Interacting Tumor-Intrinsic and Extrinsic Factors |
| Q22252595 | Obesity and cancer risk: recent review and evidence |
| Q38900947 | Obesity and cancer: inflammation bridges the two. |
| Q61799036 | Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms |
| Q37172377 | Obesity-related markers and breast cancer in CPS-II Nutrition Cohort. |
| Q30491372 | Objective Measures of Physical Activity and Cardiometabolic and Endocrine Biomarkers |
| Q37505197 | Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7) |
| Q33739214 | Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug. |
| Q47740992 | Overexpression of Insulin-Like Growth Factor-2 in Expanded Endothelial Progenitor Cells Improves Left Ventricular Function in Experimental Myocardial Infarction |
| Q37929638 | PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer |
| Q37277618 | Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer |
| Q89454638 | Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis |
| Q45022512 | Physical activity, sex steroid, and growth factor concentrations in pre- and post-menopausal women: a cross-sectional study within the EPIC cohort |
| Q33916825 | Physical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6 |
| Q37078710 | Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women |
| Q39321879 | Plasma amino acid profiles are associated with biomarkers of breast cancer risk in premenopausal Japanese women |
| Q36978703 | Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk |
| Q37592915 | Pooled cohort study on height and risk of cancer and cancer death |
| Q28069539 | Potential Mechanisms underlying the Protective Effect of Pregnancy against Breast Cancer: A Focus on the IGF Pathway |
| Q39051376 | Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell |
| Q59133082 | Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition |
| Q35609719 | Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma |
| Q89943322 | Prenatal Biochemical Screening and a Woman's Long-Term Risk of Cancer: A Population-Based Cohort Study |
| Q37308789 | Prospective association between dietary fiber intake and breast cancer risk |
| Q34335696 | Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. |
| Q40068331 | Pubertal growth and adult height in relation to breast cancer risk in African American women |
| Q35918864 | Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation |
| Q27011732 | Redefining the impact of nutrition on breast cancer incidence: is epigenetics involved? |
| Q45181207 | Relationship between concentrations of IGF-1 and IGFBP-3 and preoperative depression risk, and effect of psychological intervention on outcomes of high-grade glioma patients with preoperative depression in a 2-year prospective study |
| Q92714516 | Relationship of SNP rs35767 in IGF-1 promoter region with susceptibility to colorectal cancer |
| Q92132022 | Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy |
| Q34316229 | Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis |
| Q34988342 | Reproductive history and risk of colorectal cancer in postmenopausal women |
| Q38748114 | Resistance to Targeted Therapies in Breast Cancer |
| Q52686152 | Revisiting the IGF-1R as a breast cancer target. |
| Q40600342 | Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes. |
| Q26991921 | Risk determination and prevention of breast cancer |
| Q64936930 | Risks and benefits of consuming edible seaweeds. |
| Q41601838 | Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer |
| Q36619166 | Role of obesity in the risk of breast cancer: lessons from anthropometry |
| Q57252658 | Role of the growth hormone–IGF-1 axis in cancer |
| Q60477604 | Safety, Feasibility, and Biomarker Effects of High-Dose Vitamin D Supplementation Among Women at High Risk for Breast Cancer |
| Q35147323 | Serum IGF-1 concentrations change with soy and seaweed supplements in healthy postmenopausal American women. |
| Q35783253 | Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. |
| Q33616917 | Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis |
| Q37052561 | Serum factors and clinical characteristics associated with serum E-screen activity |
| Q52688935 | Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank. |
| Q47117659 | Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis |
| Q35111392 | Serum insulin-like growth factor-1 predicts disease progression and survival in patients with hepatocellular carcinoma who undergo transarterial chemoembolization. |
| Q60627342 | Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families |
| Q38331523 | Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions |
| Q35252793 | Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women |
| Q57794400 | Size matters: height, cell number and a person's risk of cancer |
| Q37202378 | Space radiation exposure persistently increased leptin and IGF1 in serum and activated leptin-IGF1 signaling axis in mouse intestine |
| Q91901580 | Studying the variations in differently expressed serum proteins of Hainan black goat during the breeding cycle using isobaric tags for relative and absolute quantitation (iTRAQ) technology |
| Q64255562 | Systemic Metabolism, Its Regulators, and Cancer: Past Mistakes and Future Potential |
| Q37655098 | Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples. |
| Q37137519 | The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women |
| Q42534457 | The Influence of Energetic Factors on Biomarkers of Postmenopausal Breast Cancer Risk |
| Q35914914 | The Insulin-like Growth Factor Axis, Adipokines, Physical Activity, and Obesity in Relation to Breast Cancer Incidence and Recurrence |
| Q26747486 | The Obesity-Breast Cancer Conundrum: An Analysis of the Issues |
| Q55139939 | The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma. |
| Q90151295 | The Safe and Efficacious Use of Secretome From Fibroblasts and Adipose-derived (but not Bone Marrow-derived) Mesenchymal Stem Cells for Skin Therapeutics |
| Q37035744 | The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research |
| Q36296776 | The association between adult attained height and sitting height with mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC) |
| Q35218975 | The association of alcohol consumption with mammographic density in a multiethnic urban population |
| Q63865847 | The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies |
| Q35683588 | The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study |
| Q38999289 | The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke. |
| Q36557782 | The hormonal profile of benign breast disease |
| Q27013945 | The insulin-like growth factor system in cancer |
| Q26861527 | The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise |
| Q35513693 | The interaction between early-life body size and physical activity on risk of breast cancer |
| Q35105295 | The role of the insulin-like growth factor-1 system in breast cancer |
| Q92642332 | Therapeutic Targeting of the IGF Axis |
| Q36393177 | Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study |
| Q89335873 | Usual Consumption of Specific Dairy Foods Is Associated with Breast Cancer in the Roswell Park Cancer Institute Data Bank and BioRepository |
| Q90667611 | Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort |
| Q34424169 | Validation of serum IGF-I as a biomarker to monitor the bioactivity of exogenous growth hormone agonists and antagonists in rabbits |
| Q47387270 | Waist circumference and risk of breast cancer in Korean women: A nationwide cohort study |
| Q58093715 | When is enough, enough? When are more observational epidemiologic studies needed to resolve a research question: illustrations using biomarker-cancer associations |
Search more.